ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
Rane (Madras) Limited clarified it has no comments regarding recent volume spurts. The company confirmed no impending material information or announcements requiring disclosure.
Rane (Madras) Limited has completed the acquisition of the friction business of Hindustan Composites Limited for ₹370 Crore. This transaction aligns with the previously announced Business Transfer Agreement.
Rane (Madras) reported strong Q1 FY27 results with 18.8% YoY revenue growth. Strategy focused on friction business expansion via the Hindustan Composites acquisition to create a ₹1,000+ Cr platform.
Rane (Madras) Limited appointed Mr. Pawan Kumar Choudhary as President - Compo Division, effective August 20, 2026. The appointment supports their friction business operations.
Rane (Madras) Limited completed the acquisition of the friction business of Hindustan Composites Limited as a going concern, fulfilling all customary closing conditions.
Rane (Madras) Limited concluded its 22nd Annual General Meeting on August 05, 2026. The meeting proceedings and e-voting results were formally filed with the exchanges.
Rane (Madras) Limited has re-appointed M/s. Jayaram & Associates as Cost Auditors for a 12-month term starting April 1, 2026.
Rane (Madras) Ltd reported revenue from operations of ₹1,042 Cr (+18.3% YoY) and net profit of ₹30.1 Cr (+62.7% YoY) for Q1 FY27.
Rane (Madras) Limited submitted its FY 2025-26 Annual Report and 22nd AGM notice. The meeting is scheduled for August 05, 2026, via video conferencing.
Rane (Madras) Limited scheduled its 22nd AGM for August 05, 2026. The company released its Annual Report for FY 2025-26 along with meeting details.
CRISIL upgraded Rane (Madras) Limited's long-term bank facilities rating to AA-/Stable from A+/Stable. Short-term ratings were also upgraded to A1+ for Rs.1,085 Crore facilities.